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Background: Some intervention trials have reported a reduction in systemic inflammation with the Mediterranean
diet (MedDiet) while others have observed no effect. Despite the fact that sex differences have been highlighted in
the inflammatory regulation, it is still not known whether MedDiet exerts similar effects on systemic inflammation in
men and women. The aim of this study was therefore to investigate sex differences in the effects of the MedDiet
on high-sensitivity C-reactive protein (hs-CRP).
Findings: Participants were 35 men and 27 premenopausal women (24–53 years) presenting a slightly deteriorated
lipid profile. All foods were provided to participants during a 4-week isocaloric MedDiet. At baseline, women had
higher hs-CRP concentrations than men (P = 0.03). No sex difference was observed in hs-CRP response to the
MedDiet (P for sex-by-time interaction = 0.36), with both men and women experiencing no change (respectively
P = 0.62 and P > 0.99). When subgroups were formed according to hs-CRP concentration before the MedDiet phase,
men with elevated baseline values (≥2 mg/l) experienced a reduction in hs-CRP over time with the MedDiet
(−26.5 %) while an increase was observed in men with lower baseline values (+96.6 %; P for group-by-time
interaction = 0.02). This pattern of change was not observed in women.
Conclusions: Results from this controlled feeding study suggest that men and women have similar effects from
the MedDiet on systemic inflammation. The individual’s overall inflammatory status seems to influence these effects,
but only in men.
Trial registration: This clinical trial was registered at www.clinicaltrials.gov as NCT01293344.
Keywords: Sex, Mediterranean diet, C-reactive protein, Men, WomenFindings
Introduction
The implication of low-grade, chronic inflammation in
the formation, progression and rupture of atheroscler-
otic plaques is now well-recognized [1]. Accordingly, ele-
vated C-reactive protein (CRP), a marker reflecting the
individual’s systemic inflammatory status, has been con-
sistently associated with increased risk of coronary heart
disease events [2, 3] and type 2 diabetes [4]. There is
growing evidence that adopting the traditional Mediter-
ranean diet (MedDiet) reduces systemic inflammation
[5]. The MedDiet is characterized by an abundance of* Correspondence: Simone.Lemieux@fsaa.ulaval.ca
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unless otherwise stated.plant-based foods, such as fruits, vegetables, whole grain
cereals, nuts and legumes; olive oil as the main source of
fat; moderate amounts of fish, poultry, dairy products
and eggs; relatively low amounts of red meat and sweets
and moderate amounts of red wine with meals [6]. How-
ever, even if most of the intervention trials have reported
that this food pattern reduces CRP concentrations [7–11],
some have observed no effects [12–15]. Accordingly, the
investigation of factors that may influence the anti-
inflammatory effects of this healthy food pattern is of
great interest. Sex has been highlighted as a determinant
of the inflammatory regulation. In fact women are charac-
terized by a higher inflammatory overall burden than men
[16]. Also, effects of sex hormones on inflammatory status
have been documented, estrogens being now recognized
for their anti-inflammatory properties in women [17].
However it is still not known whether MedDiet exerts the. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Servings of key foods of the Mediterranean pyramid
consumed daily during the experimental Mediterranean diet
phase for a 10 460 kJ/d (2500 kcal/d) menu
Key foodsa MedDiet (servings/d)
Olive oil (ml) 43.3
Whole grains products 5.7
Fruits and Vegetables 16.1
Legumes 0.5
Nuts 0.9








aExtra virgin and virgin olive oils were used. Serving size for whole grains
products = 125 ml (rice, pasta, bulgur, couscous), one bread piece or 30 g
cereal; Serving size for fruits and vegetables = 125 ml; Serving size for
legumes = 175 ml and for nuts = 30 g; Serving size for fish, poultry and red
meat = 75 g; Serving size for egg = 100 g; Serving size for dairy products
(mostly low fat cheese and yogurt) = 50 g cheese, 175 g yogurt and 250 ml
milk; Serving size for red wine = 150 ml
This table has been previously published in other publications [19, 21]
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of this study was therefore to investigate sex differences in
the effects of the MedDiet on high-sensitivity C-reactive
protein (hs-CRP) concentrations. As estrogens have anti-
inflammatory properties in premenopausal women [17],
and that the MedDiet has been previously shown to re-
duce estrogen concentrations in women [18], we hypothe-
sized that premenopausal women benefit less from the
anti-inflammatory effects of the MedDiet than men.
Methods
Participants
Thirty-eight men and 32 premenopausal women (24–
53 years) took part of this study. The main inclusion cri-
teria were to have a slightly elevated low-density lipoprotein
cholesterol (LDL-C) concentrations (between 3.4 and
4.9 mmol/l) or total cholesterol to high-density lipoprotein
cholesterol (HDL-C) ratio ≥5.0, and at least one of the
four following cardiovascular disease (CVD) risk factors:
waist circumference >94 cm in men and >80 cm in
women; triacylglycerol (TAG) concentration ≥1.7 mmol/l;
fasting glycemia between 6.1 and 6.9 mmol/l and/or blood
pressure levels ≥130/85 mm Hg. More details about
inclusion and exclusion criteria have been reported else-
where [19]. Women using systemic hormonal contracep-
tives were excluded. All subjects signed an informed
consent form before their inclusion in the study, which
has been approved by the Laval University Research Ethics
Committee. Power analysis indicated that a total sample
size of n = 62 is sufficient to detect significant changes in
hs-CRP concentrations (repeated measures, within-between
interaction) with a small effect-size estimate (Cohen’s d of
0.20), and with an α = 0.05 and a power (1-β error prob-
ability) of 0.95 (G*Power Version 3.0.10, Franz Faul,
Universität Kiel, Germany).
Study design
The study protocol consisted in a 4-week run-in period,
immediately followed by a 4-week fully-controlled Med-
Diet phase. Firstly, during the 4-week run-in period, par-
ticipants had to comply with the recommendations of
the Canada’s Food Guide [20] as prescribed by a regis-
tered dietician. The purpose of this run-in period was to
ensure similar dietary habits between men and women
prior the controlled MedDiet phase, a goal that has been
reached as previously reported [19]. Briefly, Canada’s
Food Guide is an educational tool which promotes
healthy eating for Canadians in order to reduce the risk
of many chronic diseases and to achieve overall health
and vitality. It indicates the recommended number of
food guide servings per day for each of the four food
groups (vegetables and fruits, grain products, milk and
alternatives, and meat and alternatives) according to the
age and sex of individuals.Thereafter, during a 4-week fully-controlled feeding
phase, subjects consumed an experimental MedDiet for-
mulated to be concordant with the characteristics of the
traditional MedDiet [6]. Details about the composition
of the MedDiet are given in Table 1 and Table 2, as pre-
viously reported in other publications [19, 21]. Subjects
were instructed to consume only the foods and bever-
ages provided to them, which corresponded to 100 % of
their estimated energy needs. More precisely, energy
needs were estimated by averaging the energy require-
ments estimated by a validated FFQ [22] administrated
at the beginning of the run-in period and energy needs
as determined by the Harris–Benedict formula. Body
weight was measured on weekdays just before lunch and
in case of body weight variation, energy intake was
modified. The amount of each food/drink provided to
each participant during the MedDiet was proportional to
his/her estimated energy needs. In order to evaluate
compliance, participants were asked to note on a check-
list foods consumed and, if needed, the amount of foods
not consumed for each day of the controlled MedDiet
phase. The overall compliance calculated from the food
checklist in men and women was respectively 97.9 ±
3.6 % and 97.6 ± 3.2 %. Since sex hormones may influ-
ence the inflammatory status [17], women’s feeding was
shortened or prolonged if needed in order to be able to
carry out all tests in the early follicular phase of their
Table 2 Daily nutritional composition of the experimental
Mediterranean diet for a 10 460 kJ/d (2500 kcal/d) menu
MedDiet
For 10 460 kJ/d (2500 kcal/d)
Energy (kJ) 10 460
Carbohydrate (% of total energy) 46.0
Fiber (g) 42.3
Protein (% of total energy) 17.0
Fat (% of total energy) 32.0
SFA (% of total energy) 6.7
MUFA (% of total energy) 18.1
PUFA (% of total energy) 4.7
Cholesterol (mg) 289.7
Alcohol (% of total energy) 5.0
MUFA to SFA ratio 2.7
Sodium (mg) 3039
MedDiet Mediterranean diet
This table has been previously published in other publications [19, 21]
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women 28.8 ± 4.3 days).
CRP measurements
Fasting blood samples were collected after the run-in
period (i.e. just before the controlled MedDiet phase,
referred as baseline values) and immediately after the
MedDiet. Serum concentrations of hs-CRP were mea-
sured using a high-sensitivity enzyme immunoassay test
kit (BioCheck Inc., Foster City, CA; coefficients of vari-
ation: intra-assay ≤ 7.5 %, inter-assay ≤ 4.1 %).Table 3 Characteristics of men and women at baselinea
Men (n = 35)
Mean SD
Age (years) 43.0 7.2
Body weight (kg)c 92.1 14.1
BMI (kg/m2)c 29.2 3.2
Waist circumference (cm)c 102.7 11.0
TAG (mmol/l)c 1.86 1.19
LDL-cholesterol (mmol/l) 3.65 0.72
HDL-cholesterol (mmol/l)c 1.12 0.30
Total cholesterol/HDL-C 5.24 1.03
Systolic blood pressure (mm Hg) 117.3 12.9
Diastolic blood pressure (mm Hg) 80.4 9.2
Fasting glucose (mmol/l) 5.87 0.37
Mediterranean score (arbitrary units)d 25.1 6.0
SD standard deviation, BMI body mass index, TAG triacylglycerol, LDL low-density lip
aThese characteristics were measured after the run-in period, i.e. immediately befor
bSex differences were determined using the Student’s t-test for unpaired data, exce
cAnalysis was performed on transformed values
dFrom 0 to 44 points, a score of 44 implies a food pattern which is perfectly concorStatistical analysis
Statistical analyses were performed with the SAS statistical
package version 9.4 (SAS Institute Inc., Cary, NC, USA).
Time and sex-by-time interaction effects on hs-CRP con-
centrations were assessed by using MIXED procedures for
repeated measurements followed by Tukey-Kramer tests.
Participants with hs-CRP concentrations greater than 10
mg/l (indicative of an acute inflammation process [23])
before or after the MedDiet phase were excluded from
our analyses (three men and five women). A P ≤ 0.05 was
considered as statistically significant.
Results
At baseline, men and women had similar mean age and
body mass index (BMI) (Table 3). However, men were
characterized by higher body weight and waist circumfer-
ence, and displayed higher values for TAG, total choles-
terol/HDL-C ratio, systolic and diastolic blood pressures
and fasting glucose, and a lower value for HDL-cholesterol
than women (Table 3). The degree of concordance of the
diet with the traditional MedDiet, as assessed by the
Mediterranean score after the run-in phase based on
the Canada’s Food Guide [24], was similar in men and
women (Table 3).
At baseline, women had higher hs-CRP concentrations
than men (1.53 ± 1.49 mg/l for men and 2.32 ± 1.63 mg/l
for women; P for sex difference = 0.03). No change was
observed for hs-CRP concentrations over time with the
MedDiet in both men and women (respectively P = 0.62
and P > 0.99, P for sex-by-time interaction = 0.36; Fig. 1).
When subgroups were formed according to hs-CRP
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Fig. 1 hs-CRP concentrations observed in men (left, n = 35) and
women (right, n = 27) at baseline and after the 4-week Mediterranean
diet. MIXED procedures for repeated measurements followed by
Tukey-Kramer tests were used. Data are means ± SEM
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Canadian guidelines for the diagnosis and treatment of
dyslipidemia and prevention of CVD in the adult [25, 26])
experienced a reduction in hs-CRP over time with the

















































Fig. 2 hs-CRP concentrations observed in men (a) and women (b) at base
baseline value. MIXED procedures for repeated measurements followed by
in men (P = 0.02) but not in women (P = 0.11). Men with hs-CRP < 2 mg/l, n
n = 12; women with hs-CRP≥ 2 mg/l, n = 15. Data are means ± SEMwith lower baseline values (<2 mg/l, +96.6 %; P for group-
by-time interaction among men = 0.02; Fig. 2a). This pat-
tern of change was not observed in women (P for group-
by-time interaction among women = 0.11; Fig. 2b).
Adjustments for the small but significant weight loss
during the MedDiet phase (−1.2 kg or 1.3 % of initial body
weight in men, P < 0.0001 and −0.6 kg or 0.7 % in women,
P = 0.04; P for sex-by-time interaction = 0.09) did not in-
fluence results obtained (not shown). Changes in body
weight during the controlled MedDiet were not associ-
ated with changes in hs-CRP concentrations (r = −0.02,
P = 0.89 in men and r = −0.13, P = 0.52 in women). No
change was observed for waist circumference in both
sexes.
Discussion
Results from this fully-controlled feeding study suggest
that men and women have similar effects from the Med-
Diet on systemic inflammation. In fact, in this sample of
individuals characterized by moderately elevated CRP
concentrations, no beneficial effects from the MedDiet
were observed, irrespective of the sex. However, results
suggest that the variability in the anti-inflammatory ef-










line and after the 4-week Mediterranean diet according to their hs-CRP
Tukey-Kramer tests were used. *A group-by-time interaction was found
= 27; men with hs-CRP≥ 2 mg/l, n = 8; women with hs-CRP < 2 mg/l,
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tion seems to be more specific to men.
Despite the fact that men and women differ substan-
tially with respect to inflammatory regulation, very lim-
ited data exist on sex differences in the impact of diet on
inflammatory status. In the case of the MedDiet, an ob-
servational study has reported reduced CRP concentra-
tions in men, but not in women, who consumed a diet
more closely in accordance with the MedDiet [27] while
another study observed this association irrespective of
the sex [28]. For interventional trials, only the Preven-
ción con Dieta Mediterránea (PREDIMED) study has
previously documented the effects of the MedDiet on in-
flammatory status taking into account the sex [11]. Their
study, consisting of a nutritional intervention among
772 high-risk individuals, indicates that the adherence to
an energy-unrestricted MedDiet supplemented with
extra-virgin olive oil reduces CRP concentrations com-
pared with a low-fat diet, with subgroup analyses show-
ing no difference between sexes. Results from our
feeding study are therefore partly in line with those from
the PREDIMED study, suggesting that the MedDiet has
similar effect on inflammation in men and women.
However, our results are in disagreement with a meta-
analysis of randomized controlled trials published in
2014 [5] which, as the PREDIMED study, reported a
reduction of CRP concentrations with the MedDiet.
However, further investigations of trials included in the
meta-analysis highlight conflicting results between stud-
ies, some reporting a reduction of systemic inflammation
with the MedDiet while almost half of the studies ob-
served no significant effects. In an effort to improve our
understanding of factors responsible for this divergence
between studies, additional analyses from the present
study suggest that the variability in the inflammatory re-
sponse to the MedDiet might be attributed in part to the
individual’s systemic inflammatory status, i.e. those with
elevated CRP concentrations having anti-inflammatory
effects from the MedDiet while those with low baseline
concentrations experiencing a clinically non-significant
increase in response to this food pattern. However this
pattern of change was more specific to men, suggesting
that sex may modulate to a certain extent the impact of
the MedDiet on the inflammatory status.
It is important to consider that participants included
in the present study were characterized by healthy diet-
ary habits at baseline. In fact, participants had to comply
with the recommendations of the Canada’s Food Guide
during the four weeks preceding the controlled MedDiet
phase [19]. It is therefore possible that changes in hs-
CRP have started during this run-in phase, limiting sub-
sequent changes during the controlled MedDiet phase.
Therefore, results from the present study should not be
over-interpreted and they suggest that, compared withthe Canada’s Food Guide recommendations, the Med-
Diet has no further impact on hs-CRP concentrations.
The small body weight loss observed during the Med-
Diet phase may be view as a limitation. However, several
studies have demonstrated that body weight loss is the
best nonpharmacologic modality to reduce inflammation
[29], which is in contrast with the nonsingnificant in-
crease in hs-CRP concentrations observed in the present
study. In addition, some studies have highlighted that a
weight loss of at least 10 % is needed to have a signifi-
cant effect on the inflammatory markers in overweight
and obese individuals [30]. Moreover, additional analyses
showed that the adjustment for body weight changes did
not influence any of the results obtained. Therefore,
these observations suggest that body weight loss ob-
served in the present study was not a major limitation.
Conclusions
Results from this feeding study suggest that the MedDiet
exerts similar effects on inflammation in men and
women. In addition, these results suggest that the vari-
ability in the anti-inflammatory effects of the MedDiet
might be attributed in part to the individual’s overall in-
flammatory status; however this observation seems to be
more specific to men. Additional clinical studies includ-
ing several inflammatory markers and a larger sample
size are of importance to further document the impact
of sex on the inflammatory response to the MedDiet.
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